Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2414 USD
−36.63 M USD
0.00 USD
6.25 M
About AEON Biopharma, Inc.
Sector
CEO
Marc Forth
Headquarters
Irvine
Website
Founded
2012
FIGI
BBG00Z17HDW3
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AEON is 0.5590 USD — it has decreased by −0.82% in the past 24 hours. Watch AEON Biopharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange AEON Biopharma, Inc. stocks are traded under the ticker AEON.
AEON stock has fallen by −20.14% compared to the previous week, the month change is a −45.73% fall, over the last year AEON Biopharma, Inc. has showed a −87.38% decrease.
We've gathered analysts' opinions on AEON Biopharma, Inc. future price: according to them, AEON price has a max estimate of 5.00 USD and a min estimate of 5.00 USD. Watch AEON chart and read a more detailed AEON Biopharma, Inc. stock forecast: see what analysts think of AEON Biopharma, Inc. and suggest that you do with its stocks.
AEON reached its all-time high on Mar 18, 2024 with the price of 17.1700 USD, and its all-time low was 0.6009 USD and was reached on Nov 15, 2024. View more price dynamics on AEON chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AEON stock is 7.16% volatile and has beta coefficient of 1.20. Track AEON Biopharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is AEON Biopharma, Inc. there?
Today AEON Biopharma, Inc. has the market capitalization of 22.53 M, it has decreased by −7.88% over the last week.
Yes, you can track AEON Biopharma, Inc. financials in yearly and quarterly reports right on TradingView.
AEON Biopharma, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
AEON earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.16 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.18 USD per share. See more details about AEON Biopharma, Inc. earnings.
AEON Biopharma, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
AEON net income for the last quarter is −6.17 M USD, while the quarter before that showed 164.11 M USD of net income which accounts for −103.76% change. Track more AEON Biopharma, Inc. financial stats to get the full picture.
No, AEON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 10.00 employees. See our rating of the largest employees — is AEON Biopharma, Inc. on this list?
Like other stocks, AEON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AEON Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AEON Biopharma, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AEON Biopharma, Inc. stock shows the strong sell signal. See more of AEON Biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.